Minerva Neurosciences | Markedsværdi

Market Capitalization Lave om Dato
Acadia Pharmaceuticals USD 5.14B 1.73B 2023-12
Adma Biologics USD 1.02B 216M 2023-12
ALKERMES USD 4.63B 36M 2023-12
Alterity Therapeutics Limited USD 11M 5M 2023-06
AstraZeneca GBP 164.29B 7.78B 2023-12
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Cipla INR 1.01T 48.59B 2023-12
Clal Biotechnology ILS 98.5M 15.84M 2022-12
Compugen ILS 629.07M 316.26M 2023-12
CSL AUD 138.48B 4.68B 2023-12
Dynavax Technologies USD 1.9B 242M 2023-09
Eli Lilly USD 731.69B 178.32B 2024-03
Esperion Therapeutics USD 340M 235M 2023-12
GlaxoSmithKline GBP 59.68B 1.42B 2023-12
Grifols USD 10.31B 2.38B 2023-12
Halozyme Therapeutics USD 4.88B 157M 2023-12
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
J&J USD 375.41B 1.91B 2024-03
Marinus Pharmaceuticals USD 407M 142M 2023-09
Merck USD 314.33B 38.07B 2024-03
Minerva Neurosciences USD 43M 5M 2023-12
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novartis CHF 193.29B 20.5B 2023-12
Novavax USD 684M 43M 2023-09
Pfizer USD 155.51B 7.05B 2024-03
Roche Holding CHF 199.67B 23.81B 2023-12
Sanofi EUR 113.53B 14.8B 2023-12
Takeda JPY 6.42T 928.65B 2023-12
Vanda Pharmaceuticals USD 243M 136M 2023-12



Minerva Neurosciences Markedsværdi - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.